GoHealth Inc has a consensus price target of $4.53 based on the ratings of 11 analysts. The high is $13 issued by RBC Capital on March 20, 2024. The low is $1 issued by Morgan Stanley on March 16, 2022. The 3 most-recent analyst ratings were released by RBC Capital, Credit Suisse, and RBC Capital on March 20, 2024, April 4, 2023, and March 17, 2023, respectively. With an average price target of $11.83 between RBC Capital, Credit Suisse, and RBC Capital, there's an implied -12.05% downside for GoHealth Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/20/2024 | Buy Now | -3.38% | RBC Capital | Ben Hendrix | $20 → $13 | Maintains | Sector Perform | Get Alert |
04/04/2023 | Buy Now | -36.82% | Credit Suisse | Jonathan Yong | $7 → $8.5 | Maintains | Underperform | Get Alert |
03/17/2023 | Buy Now | 4.06% | RBC Capital | Ben Hendrix | $15 → $14 | Maintains | Sector Perform | Get Alert |
08/26/2022 | Buy Now | -92.57% | RBC Capital | Ben Hendrix | $30 → $15 | Maintains | Sector Perform | Get Alert |
08/16/2022 | Buy Now | -90.71% | Credit Suisse | Jonathan Yong | $22.5 → $18.75 | Maintains | Underperform | Get Alert |
03/16/2022 | Buy Now | -86.99% | Evercore ISI Group | Elizabeth Anderson | $67.5 → $26.25 | Maintains | In-Line | Get Alert |
03/16/2022 | Buy Now | -92.57% | Morgan Stanley | Lauren Schenk | $45 → $15 | Maintains | Equal-Weight | Get Alert |
03/03/2022 | Buy Now | -85.13% | RBC Capital | Frank Morgan | $150 → $30 | Downgrade | Outperform → Sector Perform | Get Alert |
03/02/2022 | Buy Now | -85.13% | Truist Securities | Tobey Sommer | → $30 | Downgrade | Buy → Hold | Get Alert |
01/07/2022 | Buy Now | -77.7% | Credit Suisse | Jailendra Singh | $90 → $45 | Downgrade | Neutral → Underperform | Get Alert |
01/05/2022 | Buy Now | -73.99% | B of A Securities | Michael Cherny | $112.5 → $52.5 | Downgrade | Buy → Underperform | Get Alert |
11/15/2021 | Buy Now | -55.4% | Credit Suisse | Jailendra Singh | — | Maintains | Neutral | Get Alert |
11/11/2021 | Buy Now | -59.12% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
11/10/2021 | Buy Now | -25.67% | RBC Capital | Frank Morgan | — | Maintains | Outperform | Get Alert |
11/10/2021 | Buy Now | -62.84% | Barclays | Steve Valiquette | — | Downgrade | Overweight → Equal-Weight | Get Alert |
11/09/2021 | Buy Now | -62.84% | Barclays | Steve Valiquette | — | Downgrade | Overweight → Equal-Weight | Get Alert |
08/13/2021 | Buy Now | -25.67% | Barclays | Steve Valiquette | — | Maintains | Overweight | Get Alert |
08/12/2021 | Buy Now | -3.38% | Morgan Stanley | Lauren Schenk | — | Maintains | Equal-Weight | Get Alert |
08/12/2021 | Buy Now | — | Raymond James | C. Gregory Peters | — | Downgrade | Outperform → Market Perform | Get Alert |
08/12/2021 | Buy Now | -25.67% | Credit Suisse | Jailendra Singh | — | Downgrade | Outperform → Neutral | Get Alert |
08/12/2021 | Buy Now | -33.11% | Evercore ISI Group | Elizabeth Anderson | — | Downgrade | Outperform → In-Line | Get Alert |
The latest price target for GoHealth (NASDAQ:GOCO) was reported by RBC Capital on March 20, 2024. The analyst firm set a price target for $13.00 expecting GOCO to fall to within 12 months (a possible -3.38% downside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for GoHealth (NASDAQ:GOCO) was provided by RBC Capital, and GoHealth maintained their sector perform rating.
There is no last upgrade for GoHealth
The last downgrade for GoHealth Inc happened on March 3, 2022 when RBC Capital changed their price target from $10 to $2 for GoHealth Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GoHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GoHealth was filed on March 20, 2024 so you should expect the next rating to be made available sometime around March 20, 2025.
While ratings are subjective and will change, the latest GoHealth (GOCO) rating was a maintained with a price target of $20.00 to $13.00. The current price GoHealth (GOCO) is trading at is $13.45, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.